Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 04 Oct 2016 Last checked against the ClinicalTrials.gov record.
- 27 Sep 2016 Status changed from not yet recruiting to recruiting.
- 13 Apr 2016 New trial record